Tech Company Inital Public Offerings

Cortexyme IPO

Based in South San Francisco, Cortexyme is now a public company.

Transaction Overview

Company Name
Announced On
5/8/2019
Transaction Type
IPO
Amount
$74,800,000
Proceeds Purpose
We intend to use the net proceeds from this offering to fund our global Phase 2/3 GAIN clinical trial for COR388, and to support future clinical and preclinical activities, manufacturing and development of our library of compounds, as well as for working capital and general corporate purposes, which may include the costs of operating as a public company. We estimate that our current capital resources, along with the net proceeds from this offering, will be sufficient to fund our operating expenses and capital expenditure requirements through 2021, including through the completion and the announcement of the top-line results of our Phase 2/3 GAIN trial. However, the net proceeds from this offering, together with our current cash, will not be sufficient for us to fund the development of COR388 through regulatory approval, and we will need to raise additional capital to complete the development and commercialization of COR388.

Company Information

Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
269 East Grand Ave.
South San Francisco, CA 94080
USA
Email Address
Overview
Cortexyme (Nasdaq: CRTX) is developing treatments for Alzheimer's and other degenerative disorders.
Profile
Cortexyme LinkedIn Company Profile
Social Media
Cortexyme Company Twitter Account
Company News
Cortexyme News
Facebook
Cortexyme on Facebook
YouTube
Cortexyme on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Casey Lynch
  Casey  Lynch LinkedIn Profile  Casey  Lynch Twitter Account  Casey  Lynch News  Casey  Lynch on Facebook
Chief Scientific Officer
Stephen Dominy
  Stephen Dominy LinkedIn Profile  Stephen Dominy Twitter Account  Stephen Dominy News  Stephen Dominy on Facebook
Executive Vice President
Leslie Holsinger
  Leslie Holsinger LinkedIn Profile  Leslie Holsinger Twitter Account  Leslie Holsinger News  Leslie Holsinger on Facebook
VP - Operations
Kristen Gafric
  Kristen Gafric LinkedIn Profile  Kristen Gafric Twitter Account  Kristen Gafric News  Kristen Gafric on Facebook


 

 

Browse more venture capital transactions:

Prev: 5/8/2019: HeyJobs venture capital transaction
Next: 5/8/2019: Repair Biotechnologies venture capital transaction

 

Share this article

 


About Our VC Transactions Data

We do our best to report on every notable VC transaction. All VC database entries on this site are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary